Finance

Lists
CELC:NASDAQ
Celcuity Inc
$64.37
+0.31%
(+0.20) 1D
$64.37
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CELC...
Open
$64.20
High
$64.60
Low
$61.71
Mkt. cap
3.16B
Avg. vol.
1.58M
Volume
646.50K
52-wk high
$151.02
52-wk low
$53.54
EPS
-$4.71
Beta
0.16
Shares outstanding
49.13M
No. of employees
155
Open
$64.20
High
$64.60
Low
$61.71
Mkt. cap
3.16B
Avg. vol.
1.58M
Volume
646.50K
52-wk high
$151.02
52-wk low
$53.54
EPS
-$4.71
Beta
0.16
Shares outstanding
49.13M
No. of employees
155
News stories
From web sources and news partners
About Celcuity Inc
CEO-
Employees155
Founded2011
HeadquartersMinneapolis, Minnesota, United States
SectorHealth Care
IndustryBiotechnology
Websitecelcuity.com
Analyst ratings
Based on 9 analysts giving stock ratings to CELC in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for CELC in the last 3 months.
Highest
Current $64.37
$169.00 (+162.54%)
Average
$147.56 (+129.24%)
Lowest
$134.00 (+108.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$150.00
+133%
11/09/2026
Li Watsek
Cantor Fitzgerald
Buy
Reiterated
$140.00
+117.5%
11/05/2026
Stephen Willey
Stifel Nicolaus
Buy
Reiterated
$135.00
+109.7%
11/06/2026
Bradley Canino
Guggenheim
Buy
Reiterated
$169.00
+162.5%
11/06/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
$151.00
+134.6%
11/02/2026
Tara Bancroft
TD Cowen
Buy
Maintained
$145.00
+125.3%
10/21/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$147.00
+128.4%
10/02/2026
Gil Blum
Needham
Buy
Maintained
$134.00
+108.2%
09/30/2026
Anupam Rama
J.P. Morgan
Buy
Initiated
$157.00
+143.9%
09/17/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$165.00
+156.3%
08/14/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Maintained
$166.00
+157.9%
08/14/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
$177.00
+175%
07/15/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
$150.00
+133%
04/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
37.31M
33.06M
31.08M
37.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.89M
17.44M
35.04M
39.80M
Operating expense
49.20M
50.51M
66.12M
77.32M
Total operating expenses
49.20M
50.51M
66.12M
77.32M
Operating income
-49.20M
-50.51M
-66.12M
-77.32M
Other non operating income
-
-
-
-
EBT including unusual items
-50.97M
-52.84M
-78.86M
-73.34M
EBT excluding unusual items
-50.97M
-52.84M
-67.39M
-73.34M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-50.97M
-52.84M
-78.86M
-73.34M
Net profit margin
-
-
-
-
Earnings per share
-0.73
-0.86
-1.07
-1.21
Interest and investment income
4.39M
3.75M
4.15M
6.67M
Interest expense
-6.17M
-6.08M
-5.42M
-2.69M
Net interest expenses
-1.77M
-2.33M
-1.27M
3.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-49.15M
-50.46M
-66.06M
-77.26M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps